Meeder Asset Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-181
| Closed | -$1K | – | 2684 |
|
|
2020
Q1 | $1K | Buy |
+181
| New | +$1K | ﹤0.01% | 2286 |
|
|
2019
Q3 | – | Sell |
-289
| Closed | -$8K | – | 2334 |
|
|
2019
Q2 | $8K | Buy |
+289
| New | +$8K | ﹤0.01% | 1543 |
|
|
2018
Q1 | – | Sell |
-85
| Closed | -$4K | – | 1820 |
|
|
2017
Q4 | $4K | Sell |
85
-606
| -88% | -$28.5K | ﹤0.01% | 1398 |
|
|
2017
Q3 | $38K | Buy |
691
+357
| +107% | +$19.6K | ﹤0.01% | 743 |
|
|
2017
Q2 | $19K | Sell |
334
-153
| -31% | -$8.7K | ﹤0.01% | 840 |
|
|
2017
Q1 | $19K | Sell |
487
-409
| -46% | -$16K | ﹤0.01% | 737 |
|
|
2016
Q4 | $20K | Buy |
+896
| New | +$20K | ﹤0.01% | 661 |
|
|
2016
Q3 | – | Sell |
-3,865
| Closed | -$91K | – | 1017 |
|
|
2016
Q2 | $91K | Buy |
+3,865
| New | +$91K | 0.01% | 673 |
|